Brain, Vol. 125, No. 8, 1815-1828,
August 2002
© 2002 Guarantors of Brain
The distribution of structural neuropathology in pre-clinical Huntingtons disease
Departments of 1 Neurology and 2 Radiology, Westmead Hospital, 3 Department of Clinical Genetics, The Childrens Hospital at Westmead, NSW, Australia, 4 Wellcome Department of Imaging Neuroscience, Institute of Neurology, London, UK
Correspondence to: A. J. Duggins, Clinical Superintendent, Division of Medicine, Westmead Hospital, Hawkesbury Road, Westmead, NSW 2145, Australia E-mail: andrewd{at}westgate.wh.usyd.edu.au
Putative neuroprotective agents in Huntingtons disease may have particular application before brain pathology becomes manifest clinically. If these agents were to be tested in clinical trials, a reliable marker of the burden and rate of progression of pathological change in the pre-clinical group would be needed. The present study investigates whether the Huntingtons disease genotype is associated with regional differences in brain structure, particularly differences that could not be predicted from clinical or neuropsychological assessment. A secondary aim is to seek indirect evidence of pathological progression in the form of changes in local tissue volume with age, specific to the Huntingtons disease genotype. Formal motor examination, neuropsychological assessment, and T1-weighted cerebral MRI were performed in 34 subjects who had undergone predictive genetic testing for Huntingtons disease. Clinical and cognitive testing were performed blinded to gene status. A linear discriminant analysis revealed the combination of test scores (the optimal clinical score) which best differentiated 18 subjects carrying the Huntingtons disease gene mutation (the gene-positive group). Voxel-based morphometry (VBM) was used to identify regions of significant main effect of Huntingtons disease gene status on grey and white matter volume and regions of significant interaction of gene status with age. In the gene-positive group, there was significant reduction in grey matter volume in the left striatum, bilateral insula, dorsal midbrain and bilateral intra-parietal sulcus relative to gene-negative controls. There was a significant reduction of periventricular white matter volume with age bilaterally in the gene-positive relative to the gene-negative group. Changes remained significant when controlled for differences in optimal clinical score between subjects. This study provides evidence of distributed grey matter pathology and progressive white matter atrophy with age before clinical onset of Huntingtons disease. This suggests that VBM may be useful in monitoring cross-sectional and longitudinal changes in brain structure in pre-clinical Huntingtons disease and for determining the efficacy of neuroprotective agents.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Kloppel, B. Draganski, H. R. Siebner, S. J. Tabrizi, C. Weiller, and R. S. J. Frackowiak Functional compensation of motor function in pre-symptomatic Huntington's disease Brain, June 1, 2009; 132(6): 1624 - 1632. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Aviezer, S. Bentin, R. R. Hassin, W. S. Meschino, J. Kennedy, S. Grewal, S. Esmail, S. Cohen, and M. Moscovitch Not on the face alone: perception of contextualized face expressions in Huntington's disease Brain, June 1, 2009; 132(6): 1633 - 1644. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Muhlau, A.M. Wohlschlager, C. Gaser, M. Valet, A. Weindl, S. Nunnemann, A. Peinemann, T. Etgen, and R. Ilg Voxel-Based Morphometry in Individual Patients: A Pilot Study in Early Huntington Disease AJNR Am. J. Neuroradiol., March 1, 2009; 30(3): 539 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kloppel, C. Chu, G. C. Tan, B. Draganski, H. Johnson, J. S. Paulsen, W. Kienzle, S. J. Tabrizi, J. Ashburner, R.S.J. Frackowiak, et al. Automatic detection of preclinical neurodegeneration: Presymptomatic Huntington disease Neurology, February 3, 2009; 72(5): 426 - 431. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. De Diego-Balaguer, M. Couette, G. Dolbeau, A. Durr, K. Youssov, and A.-C. Bachoud-Levi Striatal degeneration impairs language learning: evidence from Huntington's disease Brain, November 1, 2008; 131(11): 2870 - 2881. [Abstract] [Full Text] [PDF] |
||||
![]() |
J S Paulsen, D R Langbehn, J C Stout, E Aylward, C A Ross, M Nance, M Guttman, S Johnson, M MacDonald, L J Beglinger, et al. Detection of Huntington's disease decades before diagnosis: the Predict-HD study J. Neurol. Neurosurg. Psychiatry, August 1, 2008; 79(8): 874 - 880. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ilg, A. M. Wohlschlager, C. Gaser, Y. Liebau, R. Dauner, A. Woller, C. Zimmer, J. Zihl, and M. Muhlau Gray Matter Increase Induced by Practice Correlates with Task-Specific Activation: A Combined Functional and Morphometric Magnetic Resonance Imaging Study J. Neurosci., April 16, 2008; 28(16): 4210 - 4215. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Teichmann, V. Gaura, J.-F. Demonet, F. Supiot, M. Delliaux, C. Verny, P. Renou, P. Remy, and A.-C. Bachoud-Levi Language processing within the striatum: evidence from a PET correlation study in Huntington's disease Brain, April 1, 2008; 131(4): 1046 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Rosas, D. H. Salat, S. Y. Lee, A. K. Zaleta, V. Pappu, B. Fischl, D. Greve, N. Hevelone, and S. M. Hersch Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity Brain, April 1, 2008; 131(4): 1057 - 1068. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Beste, C. Saft, J. Andrich, R. Gold, and M. Falkenstein Stimulus-Response Compatibility in Huntington's Disease: A Cognitive-Neurophysiological Analysis J Neurophysiol, March 1, 2008; 99(3): 1213 - 1223. [Abstract] [Full Text] [PDF] |
||||
![]() |
H H Ruocco, L Bonilha, L M Li, I Lopes-Cendes, and F Cendes Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat J. Neurol. Neurosurg. Psychiatry, February 1, 2008; 79(2): 130 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kloppel, B. Draganski, C. V. Golding, C. Chu, Z. Nagy, P. A. Cook, S. L. Hicks, C. Kennard, D. C. Alexander, G. J. M. Parker, et al. White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease Brain, January 1, 2008; 131(1): 196 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Garraux, P. Peigneux, R. E. Carson, and M. Hallett Task-Related Interaction between Basal Ganglia and Cortical Dopamine Release J. Neurosci., December 26, 2007; 27(52): 14434 - 14441. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Nave, S. Foresti, A. Pratesi, A. Ginestroni, M. Inzitari, E. Salvadori, M. Giannelli, S. Diciotti, D. Inzitari, and M. Mascalchi Whole-Brain Histogram and Voxel-Based Analyses of Diffusion Tensor Imaging in Patients with Leukoaraiosis: Correlation with Motor and Cognitive Impairment AJNR Am. J. Neuroradiol., August 1, 2007; 28(7): 1313 - 1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Johnson, J. C. Stout, A. C. Solomon, D. R. Langbehn, E. H. Aylward, C. B. Cruce, C. A. Ross, M. Nance, E. Kayson, E. Julian-Baros, et al. Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease Brain, July 1, 2007; 130(7): 1732 - 1744. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Daniels, M. Peller, S. Wolff, K. Alfke, K. Witt, C. Gaser, O. Jansen, H. R. Siebner, and G. Deuschl Voxel-based morphometry shows no decreases in cerebellar gray matter volume in essential tremor Neurology, October 24, 2006; 67(8): 1452 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lasek, R. Lencer, C. Gaser, J. Hagenah, U. Walter, A. Wolters, N. Kock, S. Steinlechner, M. Nagel, C. Zuhlke, et al. Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17) Brain, September 1, 2006; 129(9): 2341 - 2352. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Finke, P. Bublak, M. Dose, H. J. Muller, and W. X. Schneider Parameter-based assessment of spatial and non-spatial attentional deficits in Huntington's disease Brain, May 1, 2006; 129(5): 1137 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Suzuki, T. Hoshino, K. Shigemasu, and M. Kawamura Disgust-specific impairment of facial expression recognition in Parkinson's disease Brain, March 1, 2006; 129(3): 707 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ciarmiello, M. Cannella, S. Lastoria, M. Simonelli, L. Frati, D. C. Rubinsztein, and F. Squitieri Brain White-Matter Volume Loss and Glucose Hypometabolism Precede the Clinical Symptoms of Huntington's Disease J. Nucl. Med., February 1, 2006; 47(2): 215 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kassubek, F. D. Juengling, D. Ecker, and G. B. Landwehrmeyer Thalamic Atrophy in Huntington's Disease Co-varies with Cognitive Performance: A Morphometric MRI Analysis Cereb Cortex, June 1, 2005; 15(6): 846 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
C M Kipps, A J Duggins, N Mahant, L Gomes, J Ashburner, and E A McCusker Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study J. Neurol. Neurosurg. Psychiatry, May 1, 2005; 76(5): 650 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Calder, J. Keane, A. D. Lawrence, and F. Manes Impaired recognition of anger following damage to the ventral striatum Brain, September 1, 2004; 127(9): 1958 - 1969. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mascalchi, F. Lolli, R. D. Nave, C. Tessa, R. Petralli, C. Gavazzi, L. S. Politi, M. Macucci, M. Filippi, and S. Piacentini Huntington Disease: Volumetric, Diffusion-weighted, and Magnetization Transfer MR Imaging of Brain Radiology, September 1, 2004; 232(3): 867 - 873. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hennenlotter, U. Schroeder, P. Erhard, B. Haslinger, R. Stahl, A. Weindl, H. G. von Einsiedel, K. W. Lange, and A. O. Ceballos-Baumann Neural correlates associated with impaired disgust processing in pre-symptomatic Huntington's disease Brain, June 1, 2004; 127(6): 1446 - 1453. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Kassubek, F D Juengling, T Kioschies, K Henkel, J Karitzky, B Kramer, D Ecker, J Andrich, C Saft, P Kraus, et al. Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study J. Neurol. Neurosurg. Psychiatry, February 1, 2004; 75(2): 213 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mahant, E.A. McCusker, K. Byth, and S. Graham Huntington's disease: Clinical correlates of disability and progression Neurology, October 28, 2003; 61(8): 1085 - 1092. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Specht, M. Minnerop, M. Abele, J. Reul, U. Wullner, and T. Klockgether In Vivo Voxel-Based Morphometry in Multiple System Atrophy of the Cerebellar Type Arch Neurol, October 1, 2003; 60(10): 1431 - 1435. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Bagary, M. R. Symms, G. J. Barker, S. H. Mutsatsa, E. M. Joyce, and M. A. Ron Gray and White Matter Brain Abnormalities in First-Episode Schizophrenia Inferred From Magnetization Transfer Imaging Arch Gen Psychiatry, August 1, 2003; 60(8): 779 - 788. [Abstract] [Full Text] [PDF] |
||||
![]() |
G B Frisoni, C Testa, A Zorzan, F Sabattoli, A Beltramello, H Soininen, and M P Laakso Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry J. Neurol. Neurosurg. Psychiatry, December 1, 2002; 73(6): 657 - 664. [Abstract] [Full Text] [PDF] |
||||










